| Similar Articles |
|---|
 |
Wired
November 17, 2007
Thomas Goetz |
23AndMe Will Decode Your DNA for $1,000. Welcome to the Age of Genomics A much-anticipated Silicon Valley startup called 23andMe offers a thorough tour of your genealogy, tracing your DNA back through the eons.   |
The Motley Fool
May 28, 2010
Brian Orelli |
Is It Time to Make Money Investing in Genetic Testing? Easier said than done. |
Fast Company
November 2013
Elizabeth Murphy |
To Know You Is To Really Know You A deeper look at the makeup of genetic testing firm 23andme's customers and what their DNA reveals. |
The Motley Fool
May 23, 2007
Alyce Lomax |
Google's Generous Wedding Gift Is Google going over the line by investing in a co-founder's wife's start-up? Maybe shareholders will overlook the suggestion of sketchiness, despite the personal relationships involved and what could be interpreted as less-than-appropriate timing. |
Fast Company
December 1, 2007
Amanda Bower |
Are There Holes In My Genes? A new industry promises to gauge your genetic risk of getting diseases like cancer. Its investors, including John Doerr's Kleiner Perkins and Mark Kvamme's Sequoia Capital, have bet millions that consumers will buy it. Here, the author takes a test. |
Fast Company
November 2013
Elizabeth Murphy |
Inside 23andMe founder Anne Wojcicki's $99 DNA Revolution If Wojcicki gets it right, 23andMe could help change the health care industry as we know it. "At $99, we are opening the doors of access," she says. "Genetics is part of an entire path for how you're going to live a healthier life." |
BusinessWeek
November 7, 2005
Catherine Arnst |
How Likely Are You To Get Sick? A new DNA database could gauge your risk for disease. |
The Motley Fool
May 30, 2007
Rick Aristotle Munarriz |
Warren Buffett Is No Parrothead Jimmy Buffett and Warren Buffett aren't related. Solving the Buffett mystery illustrates how a stake in 23andMe is a good fit in Google's portfolio. Investors, take note. |
Fast Company
John Paul Titlow |
23andMe Wants To Turn Your DNA Data Into Lucrative New Drugs 23andMe's original business model may have been thwarted by the feds, but that isn't stopping the company from trying new ways to generate revenue. Its latest idea could be a lucrative one: invent new drugs. |
BusinessWeek
January 21, 2010
Rich Jaroslovsky |
Web DNA Tests Offer Ease and Enlightenment A comparison of the often entertaining services of Navigenics, 23andMe, and deCODEme. |
The Motley Fool
August 12, 2009
Brian Orelli |
The Next Big Thing Is Not Right in Front of You Perhaps the fastest evolving technology right now is found in DNA sequencing. |
BusinessWeek
August 12, 2010
Arielle Fridson |
Innovator: George Church Synthetic biologist George Church says he can create living things faster than nature can, essentially speeding up evolution. And he says he can do it cheaply. |
BusinessWeek
October 23, 2008
John Carey |
Reading the Entire Genetic Code Pioneers such as 23andMe and Navigenics use snips of genes to make medical predictions. Now new tools from more start-ups are on the horizon. |
Chemistry World
February 25, 2015
Rebecca Trager |
US opens up home DNA screening The US Food and Drug Administration has, for the first time, authorized a genetic test to be sold directly to consumers. The agency plans to ease the regulatory path for similar screening tests. |
Pharmaceutical Executive
June 1, 2011 |
To Screen or Not to Screen? What do our genetics tell us about our predisposition to certain diseases? What does this mean for pharmaceutical companies? |
Fast Company
Elizabeth Segran |
23andMe And The FDA Reached A Pivotal Genetic Testing Agreement An FDA decision summary allows DNA-testing company 23andMe to market a genome test that screens for Bloom syndrome, a rare disorder that may lead toward the development of cancer. |
Bio-IT World
February 18, 2004 |
The Quest for Complex Genes Genetic sleuths are homing in on genes for complex diseases with the help of new, and some not so new, tools and strategies. |
Bio-IT World
October 2005
Dennis A. Gilbert |
The DNA Sequencing Race: From Sprint to Marathon To create faster, cheaper, and better solutions for DNA analysis, we must remain committed to improving both current and new sequencing technologies. Research that just a short while ago might have been considered too complex, too expensive, or just inconceivable is now well within our grasp. |
Fast Company
David Lumb |
Apple Is Planning iPhone Apps That Let You Share Your DNA Down the line, these apps could let users share their DNA data just like iPhone users share their locations now, says MIT Technology Review. |
IEEE Spectrum
February 2010
Mark Anderson |
Path to the Personal Genome The next four years will be brought to you by the letters A, C, G, and T |
Wired
July 21, 2008
Thomas Goetz |
How the Personal Genome Project Could Unlock the Mysteries of Life The project will turn information from 100,000 subjects into a huge database that can reveal the connections between our genes and our physical selves. Here's how. |
Popular Mechanics
April 25, 2008
Erik Sofge |
Inside the Forgotten X Prize--the One That Can Save Your Life An extensive look at the Archon X Prize in Genomics, the $10 million race for a cheap, disease-hunting gene sequencer that could land on your kitchen counter sooner than you think. |
The Motley Fool
August 24, 2007
Brian Orelli |
Take Your Medicine; Earn Your Profits Personalized medicine offers investment ideas. Let's take a look at what this new catchphrase in the medical community actually means, and how investors can benefit from it. |
The Motley Fool
February 4, 2010
Brian Orelli |
Surfing the Wave of the Future: Personalized Medicine Medco buys in to personalized medicine. Yesterday Medco Health Solutions said it's purchasing genetic-testing expert DNA Direct. |
CIO
January 1, 2003
Alison Bass |
Big Gene Machine Five years ago, Eugene Chan, then 24, was giving up a promising medical career for the capricious future of a biotech startup. In early 2003, Chan's now 45-employee company, US Genomics, will begin selling the GeneEngine, a device that can analyze 10 million base pairs of DNA a day. |
Bio-IT World
June 17, 2004
Michael A. Goldman |
A Hip Approach to Gene Hunting IntegraGen defines the genetic blueprint of complex human diseases and delivers validated disease markers and therapeutic targets for a better diagnosis and a causal treatment of common diseases, based on its unique genomic analysis expertise. |
Bio-IT World
September 9, 2002
Malorye Branca |
The New, New Pharmacogenomics The field of pharmacogenomics proves valuable in the battle against toxicity and late-stage drug failure -- one of the pharmaceutical industry's biggest problems. |
Chemistry World
June 6, 2007
Simon Hadlington |
Large-Scale Gene Scanning for Common Diseases A multi-center genome scanning project that has analyzed half a million genetic markers in thousands of healthy people and people with a range of common diseases has revealed previously unknown genetic variants of the diseases. |
Fast Company
David Lumb |
The FDA Just OK'd 23AndMe To Test For One Syndrome The FDA just gave consumer genetics testing company 23AndMe permission to sell tests for Bloom syndrome -- a disease associated with shortened height and an increased cancer risk. |
The Motley Fool
November 14, 2006
Jack Uldrich |
Google's Diagnosis Is Good The company's ability to diagnose some diseases is yet another reason for investors to be bullish on Google's long-term prospects. |
Fast Company
David Lumb |
Sites That Sell Cancer Gene Tests Don't Tell Customers The Whole Story, Study Finds Consumer tests that analyze DNA from tumors in order to help personalize a patient's treatment are in something of a Wild West period. |
Fast Company
November 2009
David H. Freedman |
The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens. |
The Motley Fool
June 14, 2010
Bruce Bigelow |
Genetic Testing Companies in San Diego, Boston, and San Francisco Studying FDA Letters The letters notify the companies that genome-sequencing tests they offer to consumers are medical devices that require the agency's approval. |
Fast Company
Pavithra Mohan |
App Used 23andMe's DNA Database To Block People From Sites Based On Race And Gender Personal genetics company 23andMe discovered that a programmer had used its open API to create a screening mechanism for websites -- which could effectively block people by race, sex, and ancestry. |
IEEE Spectrum
March 2013
Susan Hassler |
Genome to Go It's already possible to have your own genome sequenced. But personalized medicine based on sequencing still has a way to go |
PC World
February 1, 2002
Kuriko Miyake |
Olympus Unveils DNA Computer Rather than relying on a microprocessor, computer runs on reactions between fragments of DNA... |
Science News
April 24, 2004 |
DNA Day An ivitation to commemorating the completion of the Human Genome Project in 2003 and the description of DNA's structure as a double helix in 1953. |
Fast Company
November 2013
Robert Safian |
A Code to Live By In an age of flux, there are so many emerging technologies and newly founded companies, it is near-impossible to predict which ones will have staying power. Our approach: Focus on those areas that combine cross-industry impact and human appeal. |
The Motley Fool
October 24, 2007
Brian Orelli |
Illumina's Illuminating Results There was stellar revenue growth, but margins and stock compensations pulled the bottom line down. |
Chemistry World
July 2010
Anna Lewcock |
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. |
HHMI Bulletin
May 2012
Sarah C. P. Williams |
Stephen Quake: Innovative Thinking on Genetic Tests His ideas have already led to a blood test to tell a pregnant woman whether her fetus has Down syndrome. Now, the HHMI investigator is pushing further, to track the success of heart transplants and diagnose autoimmune diseases and allergies. |
Fast Company
Christina Farr |
FDA Unveils New Site To Tailor Medical Treatment To An Individual's DNA The initiative is part of the Obama Administration's $215 million "Personalized Medicine" effort, which aims to banish the "one-sized-fits-all" approach to medicine. |
Chemistry World
April 19, 2012
Andy Extance |
Polymers perform non-DNA evolution Scientists have found that six polymer alternatives to DNA can pass on genetic information, and have evolved one type to specifically bind target molecules. |
IEEE Spectrum
August 2007
Simon A. Cole |
Double Helix Jeopardy DNA databases help solve crimes but some say they also aid and abet racial discrimination. Can there be a compromise between the desire for privacy and the need for crime control? |
Bio-IT World
June 2005
Robert M. Frederickson |
Crime Pays for DNAPrint Genomics DNAWITNESS 2.0 is used by law enforcement agencies to determine the likely genetic heritage of DNA samples obtained from crime scenes -- thereby narrowing the potential pool of suspects or victims. |
Wired
February 25, 2008
Julie Sloane |
15th Anniversary: DNA-Customized Medicine Still Stuck in the Pipeline Gene scanning isn't yet standard practice. But over the past six years, medicine has been inching closer to prescriptions that are custom-matched to a patients' DNA. |
IEEE Spectrum
March 2013
Eliza Strickland |
The Gene Machine and Me Ion Torrent's chip-based genome sequencer is cheap, fast, and poised to revolutionize medicine |
BusinessWeek
May 9, 2005
John Carey |
Dr. Francis S. Collins: On The Trail Of Disease Genes Collins is leading the search for DNA variations that can result in illnesses. |
Technology Research News
August 27, 2003 |
Detector senses single DNA Researchers from the University of California at Los Angeles have tapped differences in the folding characteristics of single-stranded and double-stranded DNA to make a sensor capable of detecting a single DNA molecule. |
Popular Mechanics
October 8, 2008
Brian Krebs |
The Internet's Top 10 Most Controversial Figures of 2008 From hackers to DNA decoders to copyright crackers, each of these people have caused enough of a stir in the online community to make their peers nervous. Here are the who's who of this year's digital underground. |
